Vilobelimab

Product Specifications

CAS Number

2250440-41-4

Target

SARS-CoV, Complement System

Related Pathways

Immunology/Inflammation, Microbiology/Virology

Purity

0.99

Bioactivity

Vilobelimab (CaCP-29) is a human-mouse chimeric IgG antibody targeting human complement component 5a, a C5a inhibitor that inhibits neutrophil activation, and can be used for the study of systemic inflammation caused by SARS-CoV-2 infection.

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

NBP2-52669AF700 0.1 mL

Rabbit Monoclonal NCAM-1/CD56 Antibody (735) [Alexa Fluor 700]

View Details

bs-4888R-BF405-01 20 µL

Phospho-PPAR Gamma (ser273) Polyclonal Antibody, AbBy Fluor™ 405 Conjugated

View Details

bs-4888R-BF405-02 100 µL

Phospho-PPAR Gamma (ser273) Polyclonal Antibody, AbBy Fluor™ 405 Conjugated

View Details

GA208027 1 Kit

Mouse Zg16 activation kit by CRISPRa

View Details

416628-01 1 g

2-Chloro-3,4-dimethoxybenzaldehyde

View Details

416628-02 5 g

2-Chloro-3,4-dimethoxybenzaldehyde

View Details